CLINICAL STUDIES
Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy
Michael Y. Henein, MD, PhD, FACCa,
Christine A. OSullivan, BSca,
Ihab S. Ramzy, MB, MSca,
Ulrich Sigwart, MD, FRCP, FACCa and
Derek G. Gibson, MB, FRCPa
a Royal Brompton Hospital, London, United Kingdom
Manuscript received October 23, 1998;
revised manuscript received May 5, 1999,
accepted June 22, 1999.
Reprint requests and correspondence: Dr. Derek G. Gibson, Royal Brompton Hospital, Sydney Street, London SW3 6NP, United Kingdom m.henein{at}rbh.nthame.nhs.uk
OBJECTIVES
To investigate the electromechanical consequences of nonsurgical septal reduction in a group of patients with hypertrophic obstructive cardiomyopathy (HOCM).
BACKGROUND
Patients with HOCM may benefit symptomatically from nonsurgical septal reduction as an alternative to dual chamber pacing and sensing (DDD) pacing and surgical myectomy.
METHODS
We studied 20 symptomatic patients with HOCM (12 men), mean age 52 ± 17 years, before and after septal reduction using echocardiography and electrocardiogram (ECG).
RESULTS
Septal reduction with a significant rise in cardiac enzymes was successfully achieved in all patients resulting in a 50% reduction in resting left ventricular (LV) outflow tract gradient within 24 h of procedure and an 80% reduction after six months. Left ventricular outflow tract diameter increased at 24 h with a further increase six months later. QRS duration increased by 35 ms at 24 h after procedure associated with right bundle branch block (RBBB) and significant rightward axis rotation in 16 patients. R-wave amplitude in V1 fell by 7 ± 4 mm in 15/20 patients, 13 of whom developed reduction of septal long axis excursion. Left-axis deviation appeared in three patients and septal q-wave was suppressed in 12 long-axis excursion; peak shortening and lengthening rates all fell at the septal site by 20% at 24 h. Only septal excursion returned back to baseline values at six months. Wall motion also became incoordinate so that postejection septal shortening increased by three times control values at 24 h and by four times six months later.
CONCLUSIONS
Nonsurgical septal reduction is associated with a drop in LV outflow tract obstruction and the creation of a localized myocardial infarction (MI) increasing LV outflow tract diameter. The technique also results in a consistent alteration of septal activation and secondary incoordination. The latter could play a significant role in gradient reduction and symptomatic improvement in a manner similar to that seen with DDD pacing.
|
Abbreviations and Acronyms
| | ANOVA | = analysis of variance | | AST | = aspartate transferase | | CK | = creatine phosphokinase | | CK-MB | = myocardial isoenzyme | | DDD | = dual chamber pacing and sensing | | ECG | = electrocardiogram | | HOCM | = hypertrophic obstructive cardiomyopathy | | LBBB | = left bundle branch block | | LV | = left ventricle or ventricular | | QTc | = QT interval corrected for heart rate | | RBBB | = right bundle branch block | | RV | = right ventricle |
|
This article has been cited by other articles:

|
 |

|
 |
 
B. J. Maron
Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
Circulation,
July 10, 2007;
116(2):
196 - 206.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. van der Lee, F. J. ten Cate, M. L. Geleijnse, M. J. Kofflard, C. Pedone, L. A. van Herwerden, E. Biagini, W. B. Vletter, and P. W. Serruys
Percutaneous Versus Surgical Treatment for Patients With Hypertrophic Obstructive Cardiomyopathy and Enlarged Anterior Mitral Valve Leaflets
Circulation,
July 26, 2005;
112(4):
482 - 488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G. van Dockum, A. M. Beek, F. J. ten Cate, J. M. ten Berg, O. Bondarenko, M. J.W. Gotte, J. W.R. Twisk, M. B.M. Hofman, C. A. Visser, and A. C. van Rossum
Early Onset and Progression of Left Ventricular Remodeling After Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
Circulation,
May 17, 2005;
111(19):
2503 - 2508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Sherrid, F. A. Chaudhry, and D. G. Swistel
Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction
Ann. Thorac. Surg.,
February 1, 2003;
75(2):
620 - 632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. F. Nagueh, S. J. Stetson, N. M. Lakkis, D. Killip, A. Perez-Verdia, M. L. Entman, W. H. Spencer III, and G. Torre-Amione
Decreased Expression of Tumor Necrosis Factor-{{alpha}} and Regression of Hypertrophy After Nonsurgical Septal Reduction Therapy for Patients With Hypertrophic Obstructive Cardiomyopathy
Circulation,
April 10, 2001;
103(14):
1844 - 1850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Flores-Ramirez, N. M. Lakkis, K. J. Middleton, D. Killip, W. H. Spencer III, and S. F. Nagueh
Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy
J. Am. Coll. Cardiol.,
January 1, 2001;
37(1):
208 - 214.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|